US Patent and Trademark Office notification
US Patent and Trademark Office (USPTO) has notified its decision to grant the 3rd Dbait patent for its standalone treatment (monotherapy) in cancer. This approval greatly strengthens the company’s IP assets, and further secures the development of its lead product.